SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

Diabetes Care. 2018 Dec;41(12):2444-2447. doi: 10.2337/dci18-0041.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Benzhydryl Compounds
  • Diabetes Mellitus, Type 1*
  • Glucosides
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Sodium-Glucose Transporter 2 Inhibitors
  • dapagliflozin